These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12728937)

  • 1. Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.
    Sakoulas G; Gold HS; Venkataraman L; Moellering RC; Ferraro MJ; Eliopoulos GM
    J Antimicrob Chemother; 2003 Apr; 51(4):1039-41. PubMed ID: 12728937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
    Mendes RE; Deshpande LM; Castanheira M; DiPersio J; Saubolle MA; Jones RN
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2244-6. PubMed ID: 18391032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistance.
    LaMarre JM; Howden BP; Mankin AS
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2989-91. PubMed ID: 21444696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
    Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
    Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the knowledge of bacterial resistance.
    Berger-Bächi B; McCallum N
    Injury; 2006 May; 37 Suppl 2():S20-5. PubMed ID: 16651067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.
    Arias CA; Vallejo M; Reyes J; Panesso D; Moreno J; Castañeda E; Villegas MV; Murray BE; Quinn JP
    J Clin Microbiol; 2008 Mar; 46(3):892-6. PubMed ID: 18174304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of linezolid against staphylococci.
    Cuny C; Witte W
    Clin Microbiol Infect; 2000 Jun; 6(6):331-3. PubMed ID: 11168144
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.
    Ho PL; Ng TK; Yung RW; Que TL; Yip EK; Tse CW; Yuen KY
    J Antimicrob Chemother; 2001 Oct; 48(4):590-2. PubMed ID: 11581246
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
    Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3651-2. PubMed ID: 14576139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
    J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z; Ofer O; Shmuely H
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
    Locke JB; Morales G; Hilgers M; G C K; Rahawi S; José Picazo J; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5352-5. PubMed ID: 20837755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
    Presterl E; Mueller-Uri P; Grisold A; Georgopoulos A; Graninger W
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):486-9. PubMed ID: 11561805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2001 Sep; 48(3):452-4. PubMed ID: 11533020
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.
    Muñoz Bellido JL; Gutiérrez Zufiaurre MN; Sánchez Hernández FJ; Yagüe Guirao G; Segovia Hernández M; García-Rodríguez JA
    Int J Antimicrob Agents; 2002 Jul; 20(1):61-4. PubMed ID: 12127713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.